Harvard Medical School has launched a new initiative for interdisciplinary research, tying together faculty and students in biology, physics, computer science, and chemistry, among others.
The new program, known as systems pharmacology, will focus on the multifaceted nature of disease and the development of therapeutic drugs.
“A traditional way to do biomedical sciences is being reinvented,” said Peter Sorger ’83, co-chair of the systems pharmacology initiative and a professor of systems biology. “It is an attempt to look at an entire network of interacting proteins. It changes the whole way the system works.”
Leaders of the initiative say they hope the new program will revolutionize disease prevention and treatment by bringing scientists together from various fields, producing concrete ways to facilitate drug development at HMS and across the pharmaceutical industry.
Through their work, researchers expect to undertake comprehensive analysis of disease pathways to create specialized target-driven drugs.
Sorger said this focus on target-driven drugs—following a mantra of one drug, one enzyme, and one disease—represents a profound change in pharmaceutical research.
“That is the real ambition here: we change the way patients are treated for really serious diseases,” Sorger said.
Sorger said the targeted-drug approach can enable a new level of drug efficacy and, in turn, patient care and compliance.
Medical schools provide the appropriate venue for the inter-disciplinary approach of systems pharmacology, according to Sorger. While other schools at Harvard, such as the Faculty of Arts and Sciences, possess the necessary resources, he said the integration of clinical and laboratory experience in medical schools is ideal for discovery and implementation. Access to both research facilities and training physicians ensures the prospect of bench-to-bedside translation.
Sorger added that the new program will involve undergraduate, graduate, and post-graduate students.
Read more in News
HUPD May Lay Off Two OfficersRecommended Articles
-
Harvard Vaccine Prevents Group B StrepA Harvard physician has developed a vaccine that could prevent thousands of babies each year from acquiring Group B streptococcus,
-
Harvard Researchers Say Use of Electronic Medical Record Systems Has Little ImpactElectronic medical record systems alone may not be enough to improve the quality of care and drive down medical costs, Harvard researchers say.
-
IT Consolidates Service Across UniversityThe consolidation of IT systems, first announced in March 2010, is scheduled to be completed this June.
-
HUIT Unification ContinuesNearly a dozen unification projects are still in the works nine months after Harvard announced the creation of Harvard University Information Technology and are projected for completion by the end of this academic year, according to Anne H. Margulies, University chief information officer.
-
Missing the PointIt is a moral obligation of college admissions to recognize that these systems of oppression exist, that they are immoral, that they operate subtly and on a broad scale, and to work to counteract them.
-
The Rulebooks in Our HeadsBut a protest is loud, and messy, and visible. It’s a spectacle, and through it we can see, hear, and otherwise physically experience power being exercised.
